Rock Springs Capital Management’s AbbVie ABBV Stock Holding History

Rock Springs Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-525,000	Closed	-$39.8M	–	131
2019 Q3	$39.8M	Buy	525,000 +375,000	+250%	+$25.7M	1.58%	16
2019 Q2	$10.9M	Buy	+150,000	New	+$11.8M	0.39%	81
2018 Q4	–	Sell	-325,000	Closed	-$30.7M	–	134
2018 Q3	$30.7M	Sell	325,000 -275,000	-46%	-$26.1M	1.11%	26
2018 Q2	$55.6M	Hold	600,000	–	–	2.14%	7
2018 Q1	$56.8M	Buy	+600,000	New	+$65.9M	2.42%	3
2016 Q1	–	Sell	-87,500	Closed	-$5.18M	–	129
2015 Q4	$5.18M	Sell	87,500 -658,923	-88%	-$38M	0.39%	82
2015 Q3	$40.6M	Hold	746,423	–	–	3.3%	3
2015 Q2	$50.2M	Buy	746,423 +146,423	+24%	+$9.56M	3.66%	1
2015 Q1	$35.1M	Buy	600,000 +20,000	+3%	+$1.21M	3.29%	2
2014 Q4	$38M	Buy	580,000 +55,000	+10%	+$3.47M	4.44%	2
2014 Q3	$30.3M	Buy	525,000 +250,000	+91%	+$13.9M	4.69%	3
2014 Q2	$15.5M	Sell	275,000 -85,000	-24%	-$4.46M	2.78%	8
2014 Q1	$18.5M	Buy	360,000 +135,000	+60%	+$6.82M	4.27%	3
2013 Q4	$11.9M	Buy	+225,000	New	+$11.1M	4.24%	4

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Rock Springs Capital Management's ABBV Position: Q4 2019 in Review

Rock Springs Capital Management sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 525,000 shares — an estimated $39.8M sold.

Rock Springs Capital Management first reported a position in ABBV in Q4 2013 and held it in 14 quarters. The position peaked at $56.8M in Q1 2018. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

Rock Springs Capital Management reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
Rock Springs Capital Management sold 525,000 AbbVie shares in Q4 2019, an estimated $39.8M.
Rock Springs Capital Management first reported a position in AbbVie in Q4 2013 and held it in 14 quarters.
Rock Springs Capital Management's AbbVie position peaked at $56.8M in Q1 2018.
2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Rock Springs Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.